CMM investigators Zhenwei Song, PhD, and Chengwen (Chengwei) Li, MD, PhD, are developing a human‑based 3D liver model through a Triangle CERSI NAMeRS award to better predict gene‑therapy toxicity, reduce reliance on animal testing, and accelerate safer therapeutic development.
Read a related article here: “CMM Faculty Contribute to New R01 Advancing Gene Therapy Safety.”
~ from UNC School of Pharmacy, “UNC Researchers Receive $2.9M Grant from NIH”